Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-04-12
DOI
10.1038/s41379-019-0270-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors
- (2017) Daniel J Farrugia et al. MODERN PATHOLOGY
- Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial
- (2016) John M. S. Bartlett et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- IHC4 score plus clinical treatment score predicts locoregional recurrence in early breast cancer
- (2016) Roopa Lakhanpal et al. BREAST
- High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial
- (2016) Torsten O. Nielsen et al. CLINICAL CANCER RESEARCH
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
- (2015) Brett Wallden et al. BMC Medical Genomics
- Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study
- (2015) B Yeo et al. BRITISH JOURNAL OF CANCER
- Risk of recurrence estimates with IHC4+C are tolerant of variations in staining and scoring: an analytical validity study
- (2015) Andrew Dodson et al. JOURNAL OF CLINICAL PATHOLOGY
- Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States
- (2015) Philip S. Rosenberg et al. JNCI-Journal of the National Cancer Institute
- Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States
- (2015) Philip S. Rosenberg et al. JNCI-Journal of the National Cancer Institute
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
- (2014) Nadia Howlader et al. JNCI-Journal of the National Cancer Institute
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- The molecular diversity of Luminal A breast tumors
- (2013) Giovanni Ciriello et al. BREAST CANCER RESEARCH AND TREATMENT
- Astronomical algorithms for automated analysis of tissue protein expression in breast cancer
- (2013) H R Ali et al. BRITISH JOURNAL OF CANCER
- Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study
- (2013) Yoshiki Mikami et al. CANCER SCIENCE
- Advances in the treatment of luminal breast cancer
- (2013) Sacha J. Howell CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis
- (2013) Molly E Klein et al. MODERN PATHOLOGY
- Luminal breast cancer: from biology to treatment
- (2013) Michail Ignatiadis et al. Nature Reviews Clinical Oncology
- Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer
- (2012) S Barton et al. BRITISH JOURNAL OF CANCER
- PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
- (2012) G C Wishart et al. BRITISH JOURNAL OF CANCER
- Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer
- (2012) Einar Gudlaugsson et al. HISTOPATHOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies
- (2010) K. L. Bolton et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: The TEAM Trial Experience
- (2009) Dana Faratian et al. HISTOPATHOLOGY
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Comprehensive immunohistochemical analysis of Her-2/neu oncoprotein overexpression in breast cancer: HercepTest™ (Dako) for manual testing and Her-2/neuTest 4B5 (Ventana) for Ventana BenchMark automatic staining system with correlation to results of fluorescence in situ hybridization (FISH)
- (2009) Doris Mayr et al. VIRCHOWS ARCHIV
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now